MediciNova

PriceMediciNova

MNOV

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Historical stock price chart and annual return over the past years

-78%

5 years

% Total

MNOV
-26%

5 years

Annual Return

MNOV